Antifungal activity of extracts and phenolic compounds from Deguelia duckeana

Detalhes bibliográficos
Autor(a) principal: Lima, Nerilson M.
Data de Publicação: 2018
Outros Autores: Cursino-Hron, Lorena M., Lima, Alita Moura, Souza, João Vicente Braga de, C., de Oliveira, André, Marinho, Jane Vasconcelos N., Nunez, C. V.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional do INPA
Texto Completo: https://repositorio.inpa.gov.br/handle/1/15597
Resumo: Candida spp. is associated with almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. In humans, Cryptococcosis is a disease of the lungs caused by the fungi Cryptococcus gattii and Cryptococcus neoformans. It can be potentially fatal, especially in immune-compromised patients. In a search for antifungal drugs, Deguelia duckeana extracts were assayed against these two fungi and also against Candida albicans, which causes candidiasis. Hexane branches and CH2Cl2 root extracts as well as the substances 4-hydroxylonchocarpine, 3,5,4′-trimethoxy-4-prenylstilbene and 3′,4′-methylenedioxy-7-methoxyflavone were assayed to determine the minimal inhibitory concentration. Phytochemical study of CH2Cl2 root and hexane branch extracts from D. duckeana A.M.G. Azevedo, Fabaceae, resulted in the isolation and characterization of nine phenolic compounds: 4-hydroxyderricine, 4-hydroxylonchocarpine, 3′,4′,7-trimethoxy-flavonol, 5,4′-dihydroxy-isolonchocarpine, 4-hydroxyderricidine, derricidine, 3,5,4′-trimethoxy-stilbene, 3′,4′,7-trimethoxyflavone and yangambin. The only active extract was a CH2Cl2 root showing minimal inhibitory concentration 800 μg/ml against C. gattii, and the investigation of compounds obtained from this extract showed that 4-hydroxylonchocarpine was active against all three fungi (C. neoformans, C. gattii and C. albicans). These results suggest that D. duckeana extracts have potential therapeutic value for the treatment of pathogenic fungi. © 2018 Sociedade Brasileira de Farmacognosia
id INPA-2_838aa8bbbca0626308003057afed35ff
oai_identifier_str oai:repositorio:1/15597
network_acronym_str INPA-2
network_name_str Repositório Institucional do INPA
repository_id_str
spelling Lima, Nerilson M.Cursino-Hron, Lorena M.Lima, Alita MouraSouza, João Vicente Braga deC., de Oliveira, AndréMarinho, Jane Vasconcelos N.Nunez, C. V.2020-05-15T14:34:13Z2020-05-15T14:34:13Z2018https://repositorio.inpa.gov.br/handle/1/1559710.1016/j.bjp.2018.08.004Candida spp. is associated with almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. In humans, Cryptococcosis is a disease of the lungs caused by the fungi Cryptococcus gattii and Cryptococcus neoformans. It can be potentially fatal, especially in immune-compromised patients. In a search for antifungal drugs, Deguelia duckeana extracts were assayed against these two fungi and also against Candida albicans, which causes candidiasis. Hexane branches and CH2Cl2 root extracts as well as the substances 4-hydroxylonchocarpine, 3,5,4′-trimethoxy-4-prenylstilbene and 3′,4′-methylenedioxy-7-methoxyflavone were assayed to determine the minimal inhibitory concentration. Phytochemical study of CH2Cl2 root and hexane branch extracts from D. duckeana A.M.G. Azevedo, Fabaceae, resulted in the isolation and characterization of nine phenolic compounds: 4-hydroxyderricine, 4-hydroxylonchocarpine, 3′,4′,7-trimethoxy-flavonol, 5,4′-dihydroxy-isolonchocarpine, 4-hydroxyderricidine, derricidine, 3,5,4′-trimethoxy-stilbene, 3′,4′,7-trimethoxyflavone and yangambin. The only active extract was a CH2Cl2 root showing minimal inhibitory concentration 800 μg/ml against C. gattii, and the investigation of compounds obtained from this extract showed that 4-hydroxylonchocarpine was active against all three fungi (C. neoformans, C. gattii and C. albicans). These results suggest that D. duckeana extracts have potential therapeutic value for the treatment of pathogenic fungi. © 2018 Sociedade Brasileira de FarmacognosiaVolume 28, Número 6, Pags. 697-702Attribution-NonCommercial-NoDerivs 3.0 Brazilhttp://creativecommons.org/licenses/by-nc-nd/3.0/br/info:eu-repo/semantics/openAccess3,4 Methylenedioxy 7 Methoxyflavone3,4,7 Trimethoxy Flavonol3,4,7 Trimethoxyflavone3,5,4 Trimethoxy 4 Prenylstilbene3,5,4 Trimethoxy Stilbene4 Hydroxyderricidine4 Hydroxyderricine4 Hydroxylonchocarpine5,4 Dihydroxy IsolonchocarpineChalcone DerivativeDeguelia Duckeana ExtractDerricidineFlavone DerivativeFlavonoidPlant ExtractPlant Medicinal ProductUnclassified DrugYangambinAnti-fungal ActivityCarbon Nuclear Magnetic ResonanceCryptococcus GattiiCryptococcus NeoformansCytotoxicityDeguelia DuckeanaLiquid Chromatography-mass SpectrometryMinimum Inhibitory ConcentrationNonhumanPhytochemistryProton Nuclear Magnetic ResonanceAntifungal activity of extracts and phenolic compounds from Deguelia duckeanainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleBrazilian Journal of Pharmacognosyengreponame:Repositório Institucional do INPAinstname:Instituto Nacional de Pesquisas da Amazônia (INPA)instacron:INPAORIGINALartigo-inpa.pdfartigo-inpa.pdfapplication/pdf663297https://repositorio.inpa.gov.br/bitstream/1/15597/1/artigo-inpa.pdf07f76f981cad39966407c53728a4128cMD511/155972020-07-14 11:24:56.154oai:repositorio:1/15597Repositório de PublicaçõesPUBhttps://repositorio.inpa.gov.br/oai/requestopendoar:2020-07-14T15:24:56Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)false
dc.title.en.fl_str_mv Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
title Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
spellingShingle Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
Lima, Nerilson M.
3,4 Methylenedioxy 7 Methoxyflavone
3,4,7 Trimethoxy Flavonol
3,4,7 Trimethoxyflavone
3,5,4 Trimethoxy 4 Prenylstilbene
3,5,4 Trimethoxy Stilbene
4 Hydroxyderricidine
4 Hydroxyderricine
4 Hydroxylonchocarpine
5,4 Dihydroxy Isolonchocarpine
Chalcone Derivative
Deguelia Duckeana Extract
Derricidine
Flavone Derivative
Flavonoid
Plant Extract
Plant Medicinal Product
Unclassified Drug
Yangambin
Anti-fungal Activity
Carbon Nuclear Magnetic Resonance
Cryptococcus Gattii
Cryptococcus Neoformans
Cytotoxicity
Deguelia Duckeana
Liquid Chromatography-mass Spectrometry
Minimum Inhibitory Concentration
Nonhuman
Phytochemistry
Proton Nuclear Magnetic Resonance
title_short Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
title_full Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
title_fullStr Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
title_full_unstemmed Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
title_sort Antifungal activity of extracts and phenolic compounds from Deguelia duckeana
author Lima, Nerilson M.
author_facet Lima, Nerilson M.
Cursino-Hron, Lorena M.
Lima, Alita Moura
Souza, João Vicente Braga de
C., de Oliveira, André
Marinho, Jane Vasconcelos N.
Nunez, C. V.
author_role author
author2 Cursino-Hron, Lorena M.
Lima, Alita Moura
Souza, João Vicente Braga de
C., de Oliveira, André
Marinho, Jane Vasconcelos N.
Nunez, C. V.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lima, Nerilson M.
Cursino-Hron, Lorena M.
Lima, Alita Moura
Souza, João Vicente Braga de
C., de Oliveira, André
Marinho, Jane Vasconcelos N.
Nunez, C. V.
dc.subject.eng.fl_str_mv 3,4 Methylenedioxy 7 Methoxyflavone
3,4,7 Trimethoxy Flavonol
3,4,7 Trimethoxyflavone
3,5,4 Trimethoxy 4 Prenylstilbene
3,5,4 Trimethoxy Stilbene
4 Hydroxyderricidine
4 Hydroxyderricine
4 Hydroxylonchocarpine
5,4 Dihydroxy Isolonchocarpine
Chalcone Derivative
Deguelia Duckeana Extract
Derricidine
Flavone Derivative
Flavonoid
Plant Extract
Plant Medicinal Product
Unclassified Drug
Yangambin
Anti-fungal Activity
Carbon Nuclear Magnetic Resonance
Cryptococcus Gattii
Cryptococcus Neoformans
Cytotoxicity
Deguelia Duckeana
Liquid Chromatography-mass Spectrometry
Minimum Inhibitory Concentration
Nonhuman
Phytochemistry
Proton Nuclear Magnetic Resonance
topic 3,4 Methylenedioxy 7 Methoxyflavone
3,4,7 Trimethoxy Flavonol
3,4,7 Trimethoxyflavone
3,5,4 Trimethoxy 4 Prenylstilbene
3,5,4 Trimethoxy Stilbene
4 Hydroxyderricidine
4 Hydroxyderricine
4 Hydroxylonchocarpine
5,4 Dihydroxy Isolonchocarpine
Chalcone Derivative
Deguelia Duckeana Extract
Derricidine
Flavone Derivative
Flavonoid
Plant Extract
Plant Medicinal Product
Unclassified Drug
Yangambin
Anti-fungal Activity
Carbon Nuclear Magnetic Resonance
Cryptococcus Gattii
Cryptococcus Neoformans
Cytotoxicity
Deguelia Duckeana
Liquid Chromatography-mass Spectrometry
Minimum Inhibitory Concentration
Nonhuman
Phytochemistry
Proton Nuclear Magnetic Resonance
description Candida spp. is associated with almost 80% of all nosocomial fungal infections and is considered a major cause of blood stream infections. In humans, Cryptococcosis is a disease of the lungs caused by the fungi Cryptococcus gattii and Cryptococcus neoformans. It can be potentially fatal, especially in immune-compromised patients. In a search for antifungal drugs, Deguelia duckeana extracts were assayed against these two fungi and also against Candida albicans, which causes candidiasis. Hexane branches and CH2Cl2 root extracts as well as the substances 4-hydroxylonchocarpine, 3,5,4′-trimethoxy-4-prenylstilbene and 3′,4′-methylenedioxy-7-methoxyflavone were assayed to determine the minimal inhibitory concentration. Phytochemical study of CH2Cl2 root and hexane branch extracts from D. duckeana A.M.G. Azevedo, Fabaceae, resulted in the isolation and characterization of nine phenolic compounds: 4-hydroxyderricine, 4-hydroxylonchocarpine, 3′,4′,7-trimethoxy-flavonol, 5,4′-dihydroxy-isolonchocarpine, 4-hydroxyderricidine, derricidine, 3,5,4′-trimethoxy-stilbene, 3′,4′,7-trimethoxyflavone and yangambin. The only active extract was a CH2Cl2 root showing minimal inhibitory concentration 800 μg/ml against C. gattii, and the investigation of compounds obtained from this extract showed that 4-hydroxylonchocarpine was active against all three fungi (C. neoformans, C. gattii and C. albicans). These results suggest that D. duckeana extracts have potential therapeutic value for the treatment of pathogenic fungi. © 2018 Sociedade Brasileira de Farmacognosia
publishDate 2018
dc.date.issued.fl_str_mv 2018
dc.date.accessioned.fl_str_mv 2020-05-15T14:34:13Z
dc.date.available.fl_str_mv 2020-05-15T14:34:13Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://repositorio.inpa.gov.br/handle/1/15597
dc.identifier.doi.none.fl_str_mv 10.1016/j.bjp.2018.08.004
url https://repositorio.inpa.gov.br/handle/1/15597
identifier_str_mv 10.1016/j.bjp.2018.08.004
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Volume 28, Número 6, Pags. 697-702
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivs 3.0 Brazil
http://creativecommons.org/licenses/by-nc-nd/3.0/br/
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Brazilian Journal of Pharmacognosy
publisher.none.fl_str_mv Brazilian Journal of Pharmacognosy
dc.source.none.fl_str_mv reponame:Repositório Institucional do INPA
instname:Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron:INPA
instname_str Instituto Nacional de Pesquisas da Amazônia (INPA)
instacron_str INPA
institution INPA
reponame_str Repositório Institucional do INPA
collection Repositório Institucional do INPA
bitstream.url.fl_str_mv https://repositorio.inpa.gov.br/bitstream/1/15597/1/artigo-inpa.pdf
bitstream.checksum.fl_str_mv 07f76f981cad39966407c53728a4128c
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Repositório Institucional do INPA - Instituto Nacional de Pesquisas da Amazônia (INPA)
repository.mail.fl_str_mv
_version_ 1809928877071400960